| UniProt ID | KKCC1_HUMAN | |
|---|---|---|
| UniProt AC | Q8N5S9 | |
| Protein Name | Calcium/calmodulin-dependent protein kinase kinase 1 | |
| Gene Name | CAMKK1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 505 | |
| Subcellular Localization | Cytoplasm. Nucleus. | |
| Protein Description | Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death.. | |
| Protein Sequence | MEGGPAVCCQDPRAELVERVAAIDVTHLEEADGGPEPTRNGVDPPPRARAASVIPGSTSRLLPARPSLSARKLSLQERPAGSYLEAQAGPYATGPASHISPRAWRRPTIESHHVAISDAEDCVQLNQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLLKQYGFPRRPPPRGSQAAQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDNLYLVFDLLRKGPVMEVPCDKPFSEEQARLYLRDVILGLEYLHCQKIVHRDIKPSNLLLGDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDSGQSFSGKALDVWATGVTLYCFVYGKCPFIDDFILALHRKIKNEPVVFPEEPEISEELKDLILKMLDKNPETRIGVPDIKLHPWVTKNGEEPLPSEEEHCSVVEVTEEEVKNSVRLIPSWTTVILVKSMLRKRSFGNPFEPQARREERSMSAPGNLLVKEGFGEGGKSPELPGVQEDEAAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 52 | Phosphorylation | PPRARAASVIPGSTS CCCHHHCCCCCCCHH | 21.42 | 23927012 | |
| 57 | Phosphorylation | AASVIPGSTSRLLPA HCCCCCCCHHHCCCC | 20.18 | 23927012 | |
| 58 | Phosphorylation | ASVIPGSTSRLLPAR CCCCCCCHHHCCCCC | 24.63 | 23927012 | |
| 59 | Phosphorylation | SVIPGSTSRLLPARP CCCCCCHHHCCCCCC | 23.72 | 23927012 | |
| 67 | Phosphorylation | RLLPARPSLSARKLS HCCCCCCCCCHHHCC | 29.42 | 25159151 | |
| 69 | Phosphorylation | LPARPSLSARKLSLQ CCCCCCCCHHHCCCC | 30.30 | 25159151 | |
| 72 | Ubiquitination | RPSLSARKLSLQERP CCCCCHHHCCCCCCC | 41.99 | - | |
| 74 | Phosphorylation | SLSARKLSLQERPAG CCCHHHCCCCCCCCC | 30.92 | 23401153 | |
| 78 | Asymmetric dimethylarginine | RKLSLQERPAGSYLE HHCCCCCCCCCCCEE | 17.26 | - | |
| 78 | Methylation | RKLSLQERPAGSYLE HHCCCCCCCCCCCEE | 17.26 | - | |
| 82 | Phosphorylation | LQERPAGSYLEAQAG CCCCCCCCCEEECCC | 28.75 | 23927012 | |
| 83 | Phosphorylation | QERPAGSYLEAQAGP CCCCCCCCEEECCCC | 13.98 | 28450419 | |
| 91 | Phosphorylation | LEAQAGPYATGPASH EEECCCCCCCCCHHH | 18.84 | 28450419 | |
| 93 | Phosphorylation | AQAGPYATGPASHIS ECCCCCCCCCHHHCC | 37.54 | 23927012 | |
| 97 | Phosphorylation | PYATGPASHISPRAW CCCCCCHHHCCCCHH | 25.20 | 23927012 | |
| 100 | Phosphorylation | TGPASHISPRAWRRP CCCHHHCCCCHHCCC | 11.69 | 25159151 | |
| 102 | Methylation | PASHISPRAWRRPTI CHHHCCCCHHCCCCC | 39.74 | - | |
| 108 | Phosphorylation | PRAWRRPTIESHHVA CCHHCCCCCCCCCEE | 35.25 | 10187789 | |
| 111 | Phosphorylation | WRRPTIESHHVAISD HCCCCCCCCCEEECC | 18.29 | 28348404 | |
| 277 | Ubiquitination | KIVHRDIKPSNLLLG EEECCCCCHHHEEEC | 46.84 | - | |
| 443 | Phosphorylation | NSVRLIPSWTTVILV HCCEECCCHHHHHHH | 30.02 | 20044836 | |
| 446 | Phosphorylation | RLIPSWTTVILVKSM EECCCHHHHHHHHHH | 10.17 | 30576142 | |
| 452 | Phosphorylation | TTVILVKSMLRKRSF HHHHHHHHHHHHCCC | 18.64 | 30576142 | |
| 458 | Phosphorylation | KSMLRKRSFGNPFEP HHHHHHCCCCCCCCH | 40.31 | 23927012 | |
| 469 | Methylation | PFEPQARREERSMSA CCCHHHHHHHHCCCC | 53.82 | - | |
| 472 | Methylation | PQARREERSMSAPGN HHHHHHHHCCCCCCC | 32.67 | - | |
| 473 | Phosphorylation | QARREERSMSAPGNL HHHHHHHCCCCCCCE | 21.99 | 30243723 | |
| 475 | Phosphorylation | RREERSMSAPGNLLV HHHHHCCCCCCCEEE | 32.34 | 25159151 | |
| 492 | Phosphorylation | GFGEGGKSPELPGVQ CCCCCCCCCCCCCCC | 27.21 | 25159151 | |
| 496 | Phosphorylation | GGKSPELPGVQEDEA CCCCCCCCCCCCCHH | 38.97 | 27251275 | |
| 505 | Phosphorylation | VQEDEAAS------- CCCCHHCC------- | 48.04 | 20068231 | |
| 513 | Phosphorylation | --------------- --------------- | 27251275 | ||
| 513 (in isoform 2) | Phosphorylation | - | 11574070 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 74 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
| 74 | S | Phosphorylation | Kinase | PRKACA | P36887 | GPS |
| 108 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 108 | T | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 475 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
| 475 | S | Phosphorylation | Kinase | PRKACA | P36887 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 458 | S | Phosphorylation |
| 18691976 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KKCC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| AAPK1_HUMAN | PRKAA1 | physical | 20801214 | |
| ANXA7_HUMAN | ANXA7 | physical | 26496610 | |
| KC1E_HUMAN | CSNK1E | physical | 26496610 | |
| DDB1_HUMAN | DDB1 | physical | 26496610 | |
| H33_HUMAN | H3F3A | physical | 26496610 | |
| NTH_HUMAN | NTHL1 | physical | 26496610 | |
| RS10_HUMAN | RPS10 | physical | 26496610 | |
| SAFB2_HUMAN | SAFB2 | physical | 26496610 | |
| NSA2_HUMAN | NSA2 | physical | 26496610 | |
| NEPRO_HUMAN | C3orf17 | physical | 26496610 | |
| FBXL6_HUMAN | FBXL6 | physical | 26496610 | |
| RNZ2_HUMAN | ELAC2 | physical | 26496610 | |
| K2013_HUMAN | KIAA2013 | physical | 26496610 | |
| BRNP1_HUMAN | BRINP1 | physical | 26496610 | |
| RUVB2_HUMAN | RUVBL2 | physical | 28514442 | |
| RUVB1_HUMAN | RUVBL1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-458 AND SER-492,AND MASS SPECTROMETRY. | |